nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefixime—Lactic dehydrogenase activity increased—Epirubicin—ovarian cancer	0.00653	0.00678	CcSEcCtD
Cefixime—Hyperbilirubinaemia—Paclitaxel—ovarian cancer	0.00642	0.00667	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Chlorambucil—ovarian cancer	0.00632	0.00657	CcSEcCtD
Cefixime—Body temperature increased—Carboplatin—ovarian cancer	0.00625	0.0065	CcSEcCtD
Cefixime—Jaundice—Chlorambucil—ovarian cancer	0.00622	0.00646	CcSEcCtD
Cefixime—Blood bilirubin increased—Paclitaxel—ovarian cancer	0.00618	0.00642	CcSEcCtD
Cefixime—Pancytopenia—Topotecan—ovarian cancer	0.00605	0.00628	CcSEcCtD
Cefixime—Lactic dehydrogenase activity increased—Doxorubicin—ovarian cancer	0.00604	0.00627	CcSEcCtD
Cefixime—Neutropenia—Topotecan—ovarian cancer	0.00596	0.00619	CcSEcCtD
Cefixime—Pancytopenia—Melphalan—ovarian cancer	0.00592	0.00615	CcSEcCtD
Cefixime—Neutropenia—Melphalan—ovarian cancer	0.00583	0.00606	CcSEcCtD
Cefixime—Blood lactate dehydrogenase increased—Epirubicin—ovarian cancer	0.00575	0.00597	CcSEcCtD
Cefixime—Colitis—Paclitaxel—ovarian cancer	0.00561	0.00583	CcSEcCtD
Cefixime—Candida infection—Paclitaxel—ovarian cancer	0.00558	0.00579	CcSEcCtD
Cefixime—Hyperbilirubinaemia—Docetaxel—ovarian cancer	0.00545	0.00566	CcSEcCtD
Cefixime—Jaundice—Melphalan—ovarian cancer	0.00542	0.00563	CcSEcCtD
Cefixime—Erythema multiforme—Chlorambucil—ovarian cancer	0.00542	0.00562	CcSEcCtD
Cefixime—Thrombocytosis—Epirubicin—ovarian cancer	0.00537	0.00558	CcSEcCtD
Cefixime—Blood lactate dehydrogenase increased—Doxorubicin—ovarian cancer	0.00532	0.00552	CcSEcCtD
Cefixime—Blood bilirubin increased—Docetaxel—ovarian cancer	0.00523	0.00544	CcSEcCtD
Cefixime—Pancytopenia—Vinorelbine—ovarian cancer	0.00517	0.00538	CcSEcCtD
Cefixime—Haemoglobin—Topotecan—ovarian cancer	0.00512	0.00532	CcSEcCtD
Cefixime—Haemorrhage—Topotecan—ovarian cancer	0.0051	0.0053	CcSEcCtD
Cefixime—Neutropenia—Vinorelbine—ovarian cancer	0.0051	0.00529	CcSEcCtD
Cefixime—Haemoglobin—Melphalan—ovarian cancer	0.00502	0.00521	CcSEcCtD
Cefixime—Hepatitis—Melphalan—ovarian cancer	0.00499	0.00519	CcSEcCtD
Cefixime—Haemorrhage—Melphalan—ovarian cancer	0.00499	0.00519	CcSEcCtD
Cefixime—Thrombocytosis—Doxorubicin—ovarian cancer	0.00497	0.00516	CcSEcCtD
Cefixime—Colitis—Docetaxel—ovarian cancer	0.00475	0.00494	CcSEcCtD
Cefixime—Candida infection—Docetaxel—ovarian cancer	0.00473	0.00491	CcSEcCtD
Cefixime—Blister—Epirubicin—ovarian cancer	0.00463	0.00481	CcSEcCtD
Cefixime—Renal failure acute—Paclitaxel—ovarian cancer	0.00459	0.00477	CcSEcCtD
Cefixime—Angioedema—Chlorambucil—ovarian cancer	0.00456	0.00473	CcSEcCtD
Cefixime—Agranulocytosis—Vinorelbine—ovarian cancer	0.00453	0.00471	CcSEcCtD
Cefixime—Leukopenia—Chlorambucil—ovarian cancer	0.00446	0.00464	CcSEcCtD
Cefixime—Renal impairment—Paclitaxel—ovarian cancer	0.00446	0.00463	CcSEcCtD
Cefixime—Convulsion—Chlorambucil—ovarian cancer	0.00432	0.00449	CcSEcCtD
Cefixime—Blister—Doxorubicin—ovarian cancer	0.00429	0.00445	CcSEcCtD
Cefixime—SLC15A1—epithelium—ovarian cancer	0.00409	0.11	CbGeAlD
Cefixime—Angioedema—Topotecan—ovarian cancer	0.00406	0.00421	CcSEcCtD
Cefixime—Thrombocytopenia—Chlorambucil—ovarian cancer	0.00398	0.00414	CcSEcCtD
Cefixime—Leukopenia—Topotecan—ovarian cancer	0.00397	0.00413	CcSEcCtD
Cefixime—Leukopenia—Melphalan—ovarian cancer	0.00389	0.00404	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Paclitaxel—ovarian cancer	0.00382	0.00397	CcSEcCtD
Cefixime—Renal impairment—Docetaxel—ovarian cancer	0.00378	0.00392	CcSEcCtD
Cefixime—Convulsion—Melphalan—ovarian cancer	0.00377	0.00391	CcSEcCtD
Cefixime—Dermatitis bullous—Docetaxel—ovarian cancer	0.00376	0.00391	CcSEcCtD
Cefixime—Hyperbilirubinaemia—Epirubicin—ovarian cancer	0.00367	0.00382	CcSEcCtD
Cefixime—SLC15A1—endometrium—ovarian cancer	0.00367	0.0983	CbGeAlD
Cefixime—Anaphylactic shock—Topotecan—ovarian cancer	0.00362	0.00376	CcSEcCtD
Cefixime—Dyspepsia—Chlorambucil—ovarian cancer	0.00358	0.00372	CcSEcCtD
Cefixime—Anaphylactic shock—Melphalan—ovarian cancer	0.00355	0.00368	CcSEcCtD
Cefixime—Thrombocytopenia—Topotecan—ovarian cancer	0.00355	0.00368	CcSEcCtD
Cefixime—Blood bilirubin increased—Epirubicin—ovarian cancer	0.00353	0.00367	CcSEcCtD
Cefixime—Pancytopenia—Paclitaxel—ovarian cancer	0.00348	0.00362	CcSEcCtD
Cefixime—Thrombocytopenia—Melphalan—ovarian cancer	0.00347	0.00361	CcSEcCtD
Cefixime—Angioedema—Vinorelbine—ovarian cancer	0.00347	0.0036	CcSEcCtD
Cefixime—Neutropenia—Paclitaxel—ovarian cancer	0.00343	0.00356	CcSEcCtD
Cefixime—Leukopenia—Vinorelbine—ovarian cancer	0.0034	0.00353	CcSEcCtD
Cefixime—Hyperbilirubinaemia—Doxorubicin—ovarian cancer	0.0034	0.00353	CcSEcCtD
Cefixime—Vaginal inflammation—Epirubicin—ovarian cancer	0.00334	0.00347	CcSEcCtD
Cefixime—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00333	0.00346	CcSEcCtD
Cefixime—Blood bilirubin increased—Doxorubicin—ovarian cancer	0.00327	0.00339	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Paclitaxel—ovarian cancer	0.00324	0.00337	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Docetaxel—ovarian cancer	0.00324	0.00336	CcSEcCtD
Cefixime—Urticaria—Chlorambucil—ovarian cancer	0.00323	0.00336	CcSEcCtD
Cefixime—Abdominal pain—Chlorambucil—ovarian cancer	0.00322	0.00334	CcSEcCtD
Cefixime—Body temperature increased—Chlorambucil—ovarian cancer	0.00322	0.00334	CcSEcCtD
Cefixime—Renal failure—Paclitaxel—ovarian cancer	0.00321	0.00334	CcSEcCtD
Cefixime—Colitis—Epirubicin—ovarian cancer	0.00321	0.00333	CcSEcCtD
Cefixime—Candida infection—Epirubicin—ovarian cancer	0.00319	0.00331	CcSEcCtD
Cefixime—Dyspepsia—Topotecan—ovarian cancer	0.00319	0.00331	CcSEcCtD
Cefixime—Urinary tract infection—Paclitaxel—ovarian cancer	0.00318	0.0033	CcSEcCtD
Cefixime—Vaginal infection—Epirubicin—ovarian cancer	0.00315	0.00328	CcSEcCtD
Cefixime—Aplastic anaemia—Epirubicin—ovarian cancer	0.00314	0.00326	CcSEcCtD
Cefixime—Dyspepsia—Melphalan—ovarian cancer	0.00312	0.00324	CcSEcCtD
Cefixime—Anaphylactic shock—Vinorelbine—ovarian cancer	0.0031	0.00322	CcSEcCtD
Cefixime—Vaginal inflammation—Doxorubicin—ovarian cancer	0.00309	0.00321	CcSEcCtD
Cefixime—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00303	0.00315	CcSEcCtD
Cefixime—Hypersensitivity—Chlorambucil—ovarian cancer	0.003	0.00311	CcSEcCtD
Cefixime—Colitis—Doxorubicin—ovarian cancer	0.00297	0.00308	CcSEcCtD
Cefixime—Gastrointestinal pain—Topotecan—ovarian cancer	0.00296	0.00308	CcSEcCtD
Cefixime—Candida infection—Doxorubicin—ovarian cancer	0.00295	0.00306	CcSEcCtD
Cefixime—Pancytopenia—Docetaxel—ovarian cancer	0.00295	0.00306	CcSEcCtD
Cefixime—Haemoglobin—Paclitaxel—ovarian cancer	0.00295	0.00306	CcSEcCtD
Cefixime—Haemorrhage—Paclitaxel—ovarian cancer	0.00293	0.00305	CcSEcCtD
Cefixime—Vaginal infection—Doxorubicin—ovarian cancer	0.00292	0.00303	CcSEcCtD
Cefixime—Neutropenia—Docetaxel—ovarian cancer	0.0029	0.00302	CcSEcCtD
Cefixime—Aplastic anaemia—Doxorubicin—ovarian cancer	0.0029	0.00301	CcSEcCtD
Cefixime—Pruritus—Chlorambucil—ovarian cancer	0.00288	0.00299	CcSEcCtD
Cefixime—Urticaria—Topotecan—ovarian cancer	0.00288	0.00299	CcSEcCtD
Cefixime—Body temperature increased—Topotecan—ovarian cancer	0.00286	0.00297	CcSEcCtD
Cefixime—Abdominal pain—Topotecan—ovarian cancer	0.00286	0.00297	CcSEcCtD
Cefixime—SLC22A5—myometrium—ovarian cancer	0.00283	0.0759	CbGeAlD
Cefixime—Urticaria—Melphalan—ovarian cancer	0.00282	0.00293	CcSEcCtD
Cefixime—Diarrhoea—Chlorambucil—ovarian cancer	0.00278	0.00289	CcSEcCtD
Cefixime—Hepatic function abnormal—Epirubicin—ovarian cancer	0.00277	0.00288	CcSEcCtD
Cefixime—Erythema multiforme—Paclitaxel—ovarian cancer	0.00277	0.00288	CcSEcCtD
Cefixime—SLC15A1—vagina—ovarian cancer	0.00275	0.0736	CbGeAlD
Cefixime—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.00275	0.00285	CcSEcCtD
Cefixime—Renal failure—Docetaxel—ovarian cancer	0.00272	0.00283	CcSEcCtD
Cefixime—Jaundice—Docetaxel—ovarian cancer	0.0027	0.0028	CcSEcCtD
Cefixime—Hypersensitivity—Topotecan—ovarian cancer	0.00267	0.00277	CcSEcCtD
Cefixime—Renal failure acute—Epirubicin—ovarian cancer	0.00263	0.00273	CcSEcCtD
Cefixime—Hypersensitivity—Melphalan—ovarian cancer	0.00261	0.00271	CcSEcCtD
Cefixime—Vomiting—Chlorambucil—ovarian cancer	0.00259	0.00269	CcSEcCtD
Cefixime—Agranulocytosis—Docetaxel—ovarian cancer	0.00258	0.00269	CcSEcCtD
Cefixime—Hepatic function abnormal—Doxorubicin—ovarian cancer	0.00257	0.00267	CcSEcCtD
Cefixime—Pruritus—Topotecan—ovarian cancer	0.00256	0.00266	CcSEcCtD
Cefixime—Renal impairment—Epirubicin—ovarian cancer	0.00255	0.00265	CcSEcCtD
Cefixime—Dermatitis bullous—Epirubicin—ovarian cancer	0.00254	0.00263	CcSEcCtD
Cefixime—SLC15A2—uterine cervix—ovarian cancer	0.00253	0.0679	CbGeAlD
Cefixime—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00253	0.00263	CcSEcCtD
Cefixime—Flatulence—Paclitaxel—ovarian cancer	0.00252	0.00261	CcSEcCtD
Cefixime—Pruritus—Melphalan—ovarian cancer	0.00251	0.00261	CcSEcCtD
Cefixime—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.0025	0.0026	CcSEcCtD
Cefixime—Haemoglobin—Docetaxel—ovarian cancer	0.0025	0.0026	CcSEcCtD
Cefixime—Hepatitis—Docetaxel—ovarian cancer	0.00249	0.00258	CcSEcCtD
Cefixime—Haemorrhage—Docetaxel—ovarian cancer	0.00249	0.00258	CcSEcCtD
Cefixime—Diarrhoea—Topotecan—ovarian cancer	0.00248	0.00257	CcSEcCtD
Cefixime—Urticaria—Vinorelbine—ovarian cancer	0.00246	0.00256	CcSEcCtD
Cefixime—Abdominal pain—Vinorelbine—ovarian cancer	0.00245	0.00254	CcSEcCtD
Cefixime—Body temperature increased—Vinorelbine—ovarian cancer	0.00245	0.00254	CcSEcCtD
Cefixime—Renal failure acute—Doxorubicin—ovarian cancer	0.00243	0.00252	CcSEcCtD
Cefixime—Diarrhoea—Melphalan—ovarian cancer	0.00243	0.00252	CcSEcCtD
Cefixime—Nausea—Chlorambucil—ovarian cancer	0.00242	0.00251	CcSEcCtD
Cefixime—Dizziness—Topotecan—ovarian cancer	0.0024	0.00249	CcSEcCtD
Cefixime—Renal impairment—Doxorubicin—ovarian cancer	0.00236	0.00245	CcSEcCtD
Cefixime—Erythema multiforme—Docetaxel—ovarian cancer	0.00235	0.00244	CcSEcCtD
Cefixime—Dermatitis bullous—Doxorubicin—ovarian cancer	0.00235	0.00244	CcSEcCtD
Cefixime—Face oedema—Epirubicin—ovarian cancer	0.00234	0.00243	CcSEcCtD
Cefixime—Angioedema—Paclitaxel—ovarian cancer	0.00233	0.00242	CcSEcCtD
Cefixime—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.00232	0.00241	CcSEcCtD
Cefixime—Vomiting—Topotecan—ovarian cancer	0.0023	0.00239	CcSEcCtD
Cefixime—SLC15A2—endometrium—ovarian cancer	0.00229	0.0614	CbGeAlD
Cefixime—Leukopenia—Paclitaxel—ovarian cancer	0.00229	0.00237	CcSEcCtD
Cefixime—Rash—Topotecan—ovarian cancer	0.00228	0.00237	CcSEcCtD
Cefixime—Hypersensitivity—Vinorelbine—ovarian cancer	0.00228	0.00237	CcSEcCtD
Cefixime—Dermatitis—Topotecan—ovarian cancer	0.00228	0.00237	CcSEcCtD
Cefixime—Headache—Topotecan—ovarian cancer	0.00227	0.00236	CcSEcCtD
Cefixime—Vomiting—Melphalan—ovarian cancer	0.00226	0.00234	CcSEcCtD
Cefixime—Rash—Melphalan—ovarian cancer	0.00224	0.00232	CcSEcCtD
Cefixime—Dermatitis—Melphalan—ovarian cancer	0.00223	0.00232	CcSEcCtD
Cefixime—Convulsion—Paclitaxel—ovarian cancer	0.00221	0.0023	CcSEcCtD
Cefixime—SLC22A5—uterine cervix—ovarian cancer	0.0022	0.0591	CbGeAlD
Cefixime—Pruritus—Vinorelbine—ovarian cancer	0.00219	0.00228	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.00218	0.00227	CcSEcCtD
Cefixime—Face oedema—Doxorubicin—ovarian cancer	0.00217	0.00225	CcSEcCtD
Cefixime—Nausea—Topotecan—ovarian cancer	0.00215	0.00223	CcSEcCtD
Cefixime—Diarrhoea—Vinorelbine—ovarian cancer	0.00212	0.0022	CcSEcCtD
Cefixime—Nausea—Melphalan—ovarian cancer	0.00211	0.00219	CcSEcCtD
Cefixime—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00208	0.00216	CcSEcCtD
Cefixime—Eosinophilia—Epirubicin—ovarian cancer	0.00207	0.00216	CcSEcCtD
Cefixime—Shock—Paclitaxel—ovarian cancer	0.00205	0.00213	CcSEcCtD
Cefixime—Dizziness—Vinorelbine—ovarian cancer	0.00205	0.00213	CcSEcCtD
Cefixime—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00204	0.00212	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.00202	0.0021	CcSEcCtD
Cefixime—SLC22A5—endometrium—ovarian cancer	0.00199	0.0534	CbGeAlD
Cefixime—Pancytopenia—Epirubicin—ovarian cancer	0.00199	0.00207	CcSEcCtD
Cefixime—Vomiting—Vinorelbine—ovarian cancer	0.00197	0.00205	CcSEcCtD
Cefixime—Neutropenia—Epirubicin—ovarian cancer	0.00196	0.00204	CcSEcCtD
Cefixime—Rash—Vinorelbine—ovarian cancer	0.00195	0.00203	CcSEcCtD
Cefixime—Dermatitis—Vinorelbine—ovarian cancer	0.00195	0.00203	CcSEcCtD
Cefixime—Headache—Vinorelbine—ovarian cancer	0.00194	0.00202	CcSEcCtD
Cefixime—Leukopenia—Docetaxel—ovarian cancer	0.00194	0.00201	CcSEcCtD
Cefixime—Eosinophilia—Doxorubicin—ovarian cancer	0.00192	0.00199	CcSEcCtD
Cefixime—SLC15A2—female reproductive system—ovarian cancer	0.0019	0.0509	CbGeAlD
Cefixime—Convulsion—Docetaxel—ovarian cancer	0.00188	0.00195	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.00185	0.00192	CcSEcCtD
Cefixime—Pancytopenia—Doxorubicin—ovarian cancer	0.00184	0.00191	CcSEcCtD
Cefixime—Nausea—Vinorelbine—ovarian cancer	0.00184	0.00191	CcSEcCtD
Cefixime—Renal failure—Epirubicin—ovarian cancer	0.00184	0.00191	CcSEcCtD
Cefixime—Dyspepsia—Paclitaxel—ovarian cancer	0.00183	0.00191	CcSEcCtD
Cefixime—Jaundice—Epirubicin—ovarian cancer	0.00182	0.00189	CcSEcCtD
Cefixime—Urinary tract infection—Epirubicin—ovarian cancer	0.00182	0.00189	CcSEcCtD
Cefixime—Neutropenia—Doxorubicin—ovarian cancer	0.00181	0.00188	CcSEcCtD
Cefixime—Anaphylactic shock—Docetaxel—ovarian cancer	0.00177	0.00184	CcSEcCtD
Cefixime—Agranulocytosis—Epirubicin—ovarian cancer	0.00174	0.00181	CcSEcCtD
Cefixime—Shock—Docetaxel—ovarian cancer	0.00174	0.00181	CcSEcCtD
Cefixime—Thrombocytopenia—Docetaxel—ovarian cancer	0.00173	0.0018	CcSEcCtD
Cefixime—SLC15A2—female gonad—ovarian cancer	0.00173	0.0463	CbGeAlD
Cefixime—SLC15A2—vagina—ovarian cancer	0.00172	0.046	CbGeAlD
Cefixime—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00171	0.00178	CcSEcCtD
Cefixime—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.0017	0.00177	CcSEcCtD
Cefixime—Renal failure—Doxorubicin—ovarian cancer	0.0017	0.00177	CcSEcCtD
Cefixime—Haemoglobin—Epirubicin—ovarian cancer	0.00169	0.00175	CcSEcCtD
Cefixime—Jaundice—Doxorubicin—ovarian cancer	0.00169	0.00175	CcSEcCtD
Cefixime—Urinary tract infection—Doxorubicin—ovarian cancer	0.00168	0.00175	CcSEcCtD
Cefixime—Haemorrhage—Epirubicin—ovarian cancer	0.00168	0.00174	CcSEcCtD
Cefixime—Hepatitis—Epirubicin—ovarian cancer	0.00168	0.00174	CcSEcCtD
Cefixime—Urticaria—Paclitaxel—ovarian cancer	0.00166	0.00172	CcSEcCtD
Cefixime—SLC22A5—female reproductive system—ovarian cancer	0.00165	0.0443	CbGeAlD
Cefixime—Body temperature increased—Paclitaxel—ovarian cancer	0.00165	0.00171	CcSEcCtD
Cefixime—Abdominal pain—Paclitaxel—ovarian cancer	0.00165	0.00171	CcSEcCtD
Cefixime—Agranulocytosis—Doxorubicin—ovarian cancer	0.00161	0.00168	CcSEcCtD
Cefixime—Erythema multiforme—Epirubicin—ovarian cancer	0.00159	0.00165	CcSEcCtD
Cefixime—Haemoglobin—Doxorubicin—ovarian cancer	0.00156	0.00162	CcSEcCtD
Cefixime—Dyspepsia—Docetaxel—ovarian cancer	0.00156	0.00162	CcSEcCtD
Cefixime—Hepatitis—Doxorubicin—ovarian cancer	0.00155	0.00161	CcSEcCtD
Cefixime—Haemorrhage—Doxorubicin—ovarian cancer	0.00155	0.00161	CcSEcCtD
Cefixime—Hypersensitivity—Paclitaxel—ovarian cancer	0.00154	0.0016	CcSEcCtD
Cefixime—SLC15A2—testis—ovarian cancer	0.00153	0.0411	CbGeAlD
Cefixime—SLC22A5—female gonad—ovarian cancer	0.0015	0.0403	CbGeAlD
Cefixime—SLC22A5—vagina—ovarian cancer	0.00149	0.04	CbGeAlD
Cefixime—Pruritus—Paclitaxel—ovarian cancer	0.00147	0.00153	CcSEcCtD
Cefixime—Erythema multiforme—Doxorubicin—ovarian cancer	0.00147	0.00152	CcSEcCtD
Cefixime—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00144	0.0015	CcSEcCtD
Cefixime—Flatulence—Epirubicin—ovarian cancer	0.00144	0.00149	CcSEcCtD
Cefixime—Diarrhoea—Paclitaxel—ovarian cancer	0.00143	0.00148	CcSEcCtD
Cefixime—Abdominal pain—Docetaxel—ovarian cancer	0.0014	0.00145	CcSEcCtD
Cefixime—Body temperature increased—Docetaxel—ovarian cancer	0.0014	0.00145	CcSEcCtD
Cefixime—Dizziness—Paclitaxel—ovarian cancer	0.00138	0.00143	CcSEcCtD
Cefixime—SLC22A5—testis—ovarian cancer	0.00133	0.0357	CbGeAlD
Cefixime—Flatulence—Doxorubicin—ovarian cancer	0.00133	0.00138	CcSEcCtD
Cefixime—Vomiting—Paclitaxel—ovarian cancer	0.00133	0.00138	CcSEcCtD
Cefixime—Rash—Paclitaxel—ovarian cancer	0.00131	0.00137	CcSEcCtD
Cefixime—Dermatitis—Paclitaxel—ovarian cancer	0.00131	0.00136	CcSEcCtD
Cefixime—Leukopenia—Epirubicin—ovarian cancer	0.00131	0.00136	CcSEcCtD
Cefixime—Headache—Paclitaxel—ovarian cancer	0.00131	0.00136	CcSEcCtD
Cefixime—Hypersensitivity—Docetaxel—ovarian cancer	0.0013	0.00135	CcSEcCtD
Cefixime—Convulsion—Epirubicin—ovarian cancer	0.00126	0.00131	CcSEcCtD
Cefixime—Pruritus—Docetaxel—ovarian cancer	0.00125	0.0013	CcSEcCtD
Cefixime—Nausea—Paclitaxel—ovarian cancer	0.00124	0.00129	CcSEcCtD
Cefixime—Leukopenia—Doxorubicin—ovarian cancer	0.00121	0.00126	CcSEcCtD
Cefixime—Diarrhoea—Docetaxel—ovarian cancer	0.00121	0.00126	CcSEcCtD
Cefixime—Anaphylactic shock—Epirubicin—ovarian cancer	0.00119	0.00124	CcSEcCtD
Cefixime—Shock—Epirubicin—ovarian cancer	0.00117	0.00122	CcSEcCtD
Cefixime—Convulsion—Doxorubicin—ovarian cancer	0.00117	0.00122	CcSEcCtD
Cefixime—Dizziness—Docetaxel—ovarian cancer	0.00117	0.00121	CcSEcCtD
Cefixime—Thrombocytopenia—Epirubicin—ovarian cancer	0.00117	0.00121	CcSEcCtD
Cefixime—Vomiting—Docetaxel—ovarian cancer	0.00112	0.00117	CcSEcCtD
Cefixime—Rash—Docetaxel—ovarian cancer	0.00111	0.00116	CcSEcCtD
Cefixime—Dermatitis—Docetaxel—ovarian cancer	0.00111	0.00116	CcSEcCtD
Cefixime—SLC15A2—lymph node—ovarian cancer	0.00111	0.0298	CbGeAlD
Cefixime—Headache—Docetaxel—ovarian cancer	0.00111	0.00115	CcSEcCtD
Cefixime—Anaphylactic shock—Doxorubicin—ovarian cancer	0.0011	0.00115	CcSEcCtD
Cefixime—Shock—Doxorubicin—ovarian cancer	0.00108	0.00113	CcSEcCtD
Cefixime—Thrombocytopenia—Doxorubicin—ovarian cancer	0.00108	0.00112	CcSEcCtD
Cefixime—Nausea—Docetaxel—ovarian cancer	0.00105	0.00109	CcSEcCtD
Cefixime—Dyspepsia—Epirubicin—ovarian cancer	0.00105	0.00109	CcSEcCtD
Cefixime—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000974	0.00101	CcSEcCtD
Cefixime—Dyspepsia—Doxorubicin—ovarian cancer	0.00097	0.00101	CcSEcCtD
Cefixime—SLC22A5—lymph node—ovarian cancer	0.000966	0.0259	CbGeAlD
Cefixime—Urticaria—Epirubicin—ovarian cancer	0.000947	0.000983	CcSEcCtD
Cefixime—Abdominal pain—Epirubicin—ovarian cancer	0.000942	0.000978	CcSEcCtD
Cefixime—Body temperature increased—Epirubicin—ovarian cancer	0.000942	0.000978	CcSEcCtD
Cefixime—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000902	0.000936	CcSEcCtD
Cefixime—Hypersensitivity—Epirubicin—ovarian cancer	0.000878	0.000912	CcSEcCtD
Cefixime—Urticaria—Doxorubicin—ovarian cancer	0.000876	0.00091	CcSEcCtD
Cefixime—Abdominal pain—Doxorubicin—ovarian cancer	0.000872	0.000905	CcSEcCtD
Cefixime—Body temperature increased—Doxorubicin—ovarian cancer	0.000872	0.000905	CcSEcCtD
Cefixime—Pruritus—Epirubicin—ovarian cancer	0.000843	0.000876	CcSEcCtD
Cefixime—Diarrhoea—Epirubicin—ovarian cancer	0.000815	0.000847	CcSEcCtD
Cefixime—Hypersensitivity—Doxorubicin—ovarian cancer	0.000812	0.000844	CcSEcCtD
Cefixime—Dizziness—Epirubicin—ovarian cancer	0.000788	0.000818	CcSEcCtD
Cefixime—Pruritus—Doxorubicin—ovarian cancer	0.00078	0.00081	CcSEcCtD
Cefixime—Vomiting—Epirubicin—ovarian cancer	0.000758	0.000787	CcSEcCtD
Cefixime—Diarrhoea—Doxorubicin—ovarian cancer	0.000754	0.000784	CcSEcCtD
Cefixime—Rash—Epirubicin—ovarian cancer	0.000751	0.00078	CcSEcCtD
Cefixime—Dermatitis—Epirubicin—ovarian cancer	0.000751	0.00078	CcSEcCtD
Cefixime—Headache—Epirubicin—ovarian cancer	0.000746	0.000775	CcSEcCtD
Cefixime—Dizziness—Doxorubicin—ovarian cancer	0.000729	0.000757	CcSEcCtD
Cefixime—Nausea—Epirubicin—ovarian cancer	0.000708	0.000735	CcSEcCtD
Cefixime—Vomiting—Doxorubicin—ovarian cancer	0.000701	0.000728	CcSEcCtD
Cefixime—Rash—Doxorubicin—ovarian cancer	0.000695	0.000722	CcSEcCtD
Cefixime—Dermatitis—Doxorubicin—ovarian cancer	0.000695	0.000721	CcSEcCtD
Cefixime—Headache—Doxorubicin—ovarian cancer	0.000691	0.000717	CcSEcCtD
Cefixime—Nausea—Doxorubicin—ovarian cancer	0.000655	0.00068	CcSEcCtD
